Remdesivir and Lopinavir/Ritonavir as Potential Drugs to Treat Coronavirus Disease 2019 (COVID-19)

Bzikha Reda; Bouhmou Ayoub; Bzikha Ilham; Bouchnafati Sanaa

Abstract

Remdesivir and Lopinavir/Ritonavir as Potential Drugs to Treat Coronavirus Disease 2019 (COVID-19)

Drugs that are efficacious against SARS-CoV-2 have yet to be established. Remdesivir and Lopinavir/ritonavir have garnered considerable attention for their potential to treat coronavirus disease 2019 (COVID-19).

Remdesivir not only in vivo but also in vitro testing shows the inhibition of human coronavirus replication, including SARS-CoV-2 as well as Lopinavir/ritonavir that shows promising antiviral drug against SARS-CoV-2.

Author(s):

Bzikha Reda^*, Bouhmou Ayoub, Bzikha Ilham, Bouchnafati Sanaa

Abstract | Full-Text | PDF

Share this